Ballabio et al. reported that the concentration of miRNA-27a was reduced in BTZ-resistant MM cells and the ectopic expression of miRNA-27a resensitized these cells to BTZ via reducing CDK5, which acts as an oncogene and is correlated with reduced survival in MM patients [42,43]. The gene discussed is CDK5; the disease is Miyoshi myopathy.